Newman Michael James (CIK 0001876315)

Latest company ownership

INDP - Indaptus Therapeutics, Inc.
Role: CSO and Director
Shares held
43,250
Last filed at
Jan 23, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 31, 2022 Feb 2, 2022 Indaptus Therapeutics, Inc. CSO and Director Sell 45.0 -20,000 -1.44% ✓ $100K